Loading image…
This image couldn’t load. Please try another view.
Loading image…
This image couldn’t load. Please try another view.
Loading image…
This image couldn’t load. Please try another view.
Loading image…
This image couldn’t load. Please try another view.
Loading image…
This image couldn’t load. Please try another view.
Tirzepatide
Peptide
A peptide that acts on GIP and GLP-1 receptors, studied in weight management.
Research findings do not establish benefits from this product.
$99.99 CAD
- Listed contents
- 10 mg
- Bottle capacity
- 3 mL
- Pack size
- 1 bottle
Ordering opens soon.
A closer look
at Tirzepatide.
About Tirzepatide
In the SURMOUNT-1 trial lasting 72 weeks, adults with obesity or overweight and a related condition lost more weight with tirzepatide than with placebo. Participants also received a lifestyle intervention.
Digestive side effects were common. The findings apply to the trial medicine and its supervised use; this catalogue vial has not been shown to be equivalent to that medicine.
Sources & context
These sources describe the compound or named medicine, not testing of this Diosa product. Personal health questions belong with a qualified healthcare professional.
Product details
- Product
- Tirzepatide
- Listed contents
- 10 mg
- Bottle capacity
- 3 mL
- Pack size
- 1 bottle
Questions?
We’re here to help with product details and shopping questions.
Ask Diosas Browse the FAQ
